AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 172, Issue 9, Pages 2406-2418
Publisher
Wiley
Online
2015-01-09
DOI
10.1111/bph.13069
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetics and Pharmacodynamics of Phenethyl Isothiocyanate: Implications in Breast Cancer Prevention
- (2014) Marilyn E. Morris et al. AAPS Journal
- 2012 Division of Medicinal Chemistry Award Address. Trekking the Cannabinoid Road: A Personal Perspective
- (2014) Alexandros Makriyannis JOURNAL OF MEDICINAL CHEMISTRY
- Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not “higher”
- (2014) Y. Nasser et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Adverse Health Effects of Marijuana Use
- (2014) Nora D. Volkow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors
- (2014) Jakub Fichna et al. PLoS One
- Cannabinoid 1 receptors are critical for the innate immune response to TLR4 stimulation
- (2013) Marnie Duncan et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Peripherally restricted CB1 receptor blockers
- (2013) Robert J. Chorvat BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome
- (2013) Michael Camilleri EXPERT OPINION ON PHARMACOTHERAPY
- Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists
- (2013) Gareth Pryce et al. FASEB JOURNAL
- Moving around the molecule: Relationship between chemical structure and in vivo activity of synthetic cannabinoids
- (2013) Jenny L. Wiley et al. LIFE SCIENCES
- More surprises lying ahead. The endocannabinoids keep us guessing
- (2013) Daniele Piomelli NEUROPHARMACOLOGY
- The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
- (2013) Adam J. Pawson et al. NUCLEIC ACIDS RESEARCH
- The Pharmacologic and Clinical Effects of Medical Cannabis
- (2013) Laura M. Borgelt et al. PHARMACOTHERAPY
- Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain
- (2012) Julia M. Adam et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
- (2012) Joseph Tam et al. Cell Metabolism
- Plasticity of mouse enteric synapses mediated through endocannabinoid and purinergic signaling
- (2012) I. M. Hons et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea
- (2012) B. S. Wong et al. NEUROGASTROENTEROLOGY AND MOTILITY
- The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility
- (2012) Raquel Abalo et al. PHARMACOLOGY
- Why do cannabinoid receptors have more than one endogenous ligand?
- (2012) V. Di Marzo et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- The CB1 cannabinoid receptor C-terminus regulates receptor desensitization in autaptic hippocampal neurones
- (2011) Alex Straiker et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice
- (2011) M Bashashati et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients With Nonconstipated Irritable Bowel Syndrome
- (2011) Banny S. Wong et al. GASTROENTEROLOGY
- Mass Spectrometry-based Proteomics of Human Cannabinoid Receptor 2: Covalent Cysteine 6.47(257)-Ligand Interaction Affording Megagonist Receptor Activation
- (2011) Dennis W. Szymanski et al. JOURNAL OF PROTEOME RESEARCH
- Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects
- (2011) Elizabeth J. Rahn et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Guidelines for reporting experiments involving animals: the ARRIVE guidelines
- (2010) JC McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents
- (2010) NL Cluny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Lipid Pathway for Ligand Binding Is Necessary for a Cannabinoid G Protein-coupled Receptor
- (2010) Dow P. Hurst et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a Peripherally Restricted Cannabinoid CB1/CB2 Receptor Agonist, Inhibits Gastrointestinal Motility but Has No Effect on Experimental Colitis in Mice
- (2010) N. L. Cluny et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Differential effects of CB1 neutral antagonists and inverse agonists on gastrointestinal motility in mice
- (2010) M. A. Storr et al. NEUROGASTROENTEROLOGY AND MOTILITY
- A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain
- (2010) Xiao Hong Yu et al. PAIN
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- Cannabinoids and the gut: New developments and emerging concepts
- (2010) Angelo A. Izzo et al. PHARMACOLOGY & THERAPEUTICS
- Interaction between cannabinoid CB1receptors and endogenous ATP in the control of spontaneous mechanical activity in mouse ileum
- (2009) S Baldassano et al. BRITISH JOURNAL OF PHARMACOLOGY
- The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice
- (2009) n. l. cluny et al. NEUROGASTROENTEROLOGY AND MOTILITY
- PKCɛ Regulates Behavioral Sensitivity, Binding and Tolerance to the CB1 Receptor Agonist WIN55,212-2
- (2009) Melisa J Wallace et al. NEUROPSYCHOPHARMACOLOGY
- Ligand-Binding Architecture of Human CB2 Cannabinoid Receptor: Evidence for Receptor Subtype-Specific Binding Motif and Modeling GPCR Activation
- (2008) Ying Pei et al. CHEMISTRY & BIOLOGY
- A Saturated N-Acylethanolamine Other than N-Palmitoyl Ethanolamine with Anti-inflammatory Properties: a Neglected Story…
- (2008) M. Dalle Carbonare et al. JOURNAL OF NEUROENDOCRINOLOGY
- Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?
- (2008) George Kunos et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling
- (2007) Tanya L. Daigle et al. NEUROPHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now